You are reading a single comment by @jellybaby and its replies.
Click here to read the full conversation.
-
Probably. It assumes the trial will be successful both from an effectiveness perspective and side effects (roll something out to billions of people and a low rate of something undesirable happens a lot). I hope it is but I think we should plan that it isn't.
Even then I'm not sure how many doses will be available in September. First priority are health care workers and the over 50s. When they are vaccinated do we all go back to the office or not until your name gets to the top of the list?
jellybaby
Isn't the assumption based on the fact that Astrazeneca are already producing the vaccine? It is still in phase 3 trial but they are producing it already on the assumption it can be on the shelves ready for roll out as soon as the trial concludes